962 related articles for article (PubMed ID: 28107283)
1. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).
Vos MB; Abrams SH; Barlow SE; Caprio S; Daniels SR; Kohli R; Mouzaki M; Sathya P; Schwimmer JB; Sundaram SS; Xanthakos SA
J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):319-334. PubMed ID: 28107283
[TBL] [Abstract][Full Text] [Related]
2. Management of NAFLD: a stage-based approach.
Rinella ME; Sanyal AJ
Nat Rev Gastroenterol Hepatol; 2016 Apr; 13(4):196-205. PubMed ID: 26907882
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
Carr RM; Oranu A; Khungar V
Gastroenterol Clin North Am; 2016 Dec; 45(4):639-652. PubMed ID: 27837778
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Watanabe S; Hashimoto E; Ikejima K; Uto H; Ono M; Sumida Y; Seike M; Takei Y; Takehara T; Tokushige K; Nakajima A; Yoneda M; Saibara T; Shiota G; Sakaida I; Nakamuta M; Mizuta T; Tsubouchi H; Sugano K; Shimosegawa T; ;
J Gastroenterol; 2015 Apr; 50(4):364-77. PubMed ID: 25708290
[TBL] [Abstract][Full Text] [Related]
5. Urinary thiodiglycolic acid is associated with increased risk of non-alcoholic fatty liver disease in children living near a petrochemical complex.
Wang CW; Chuang HY; Liao KW; Yu ML; Dai CY; Chang WT; Tsai CH; Chiang HC; Huang PC
Environ Int; 2019 Oct; 131():104978. PubMed ID: 31325714
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease: Evolving paradigms.
Lonardo A; Nascimbeni F; Maurantonio M; Marrazzo A; Rinaldi L; Adinolfi LE
World J Gastroenterol; 2017 Sep; 23(36):6571-6592. PubMed ID: 29085206
[TBL] [Abstract][Full Text] [Related]
7. Management of Pediatric Nonalcoholic Fatty Liver Disease by Academic Hepatologists in Canada: A Nationwide Survey.
Mouzaki M; Ling SC; Schreiber RA; Kamath BM
J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):380-383. PubMed ID: 28333768
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease in children: recent practice guidelines, where do they take us?
Aggarwal A; Puri K; Thangada S; Zein N; Alkhouri N
Curr Pediatr Rev; 2014; 10(2):151-61. PubMed ID: 25088269
[TBL] [Abstract][Full Text] [Related]
9. Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease.
Lin CH; Kohli R
Curr Gastroenterol Rep; 2020 Aug; 22(10):52. PubMed ID: 32814993
[TBL] [Abstract][Full Text] [Related]
10. Overview of Pediatric Nonalcoholic Fatty Liver Disease: A Guide for General Practitioners.
Shakir AK; Suneja U; Short KR; Palle S
J Okla State Med Assoc; 2018 Oct; 111(8):806-811. PubMed ID: 31303681
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study.
Shaheen AA; Riazi K; Medellin A; Bhayana D; Kaplan GG; Jiang J; Park R; Schaufert W; Burak KW; Sargious M; Swain MG
CMAJ Open; 2020; 8(2):E370-E376. PubMed ID: 32414883
[TBL] [Abstract][Full Text] [Related]
12. [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].
Kim SK; Kim KI; Kim SR
Yakugaku Zasshi; 2019; 139(9):1147-1153. PubMed ID: 31474630
[TBL] [Abstract][Full Text] [Related]
13. Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.
Arab JP; Candia R; Zapata R; Muñoz C; Arancibia JP; Poniachik J; Soza A; Fuster F; Brahm J; Sanhueza E; Contreras J; Cuellar MC; Arrese M; Riquelme A
World J Gastroenterol; 2014 Sep; 20(34):12182-201. PubMed ID: 25232252
[TBL] [Abstract][Full Text] [Related]
14. Evolution of NAFLD and Its Management.
Mundi MS; Velapati S; Patel J; Kellogg TA; Abu Dayyeh BK; Hurt RT
Nutr Clin Pract; 2020 Feb; 35(1):72-84. PubMed ID: 31840865
[TBL] [Abstract][Full Text] [Related]
15. The pharmacological treatment of nonalcoholic fatty liver disease in children.
Crudele A; Panera N; Braghini MR; Balsano C; Alisi A
Expert Rev Clin Pharmacol; 2020 Nov; 13(11):1219-1227. PubMed ID: 32981386
[TBL] [Abstract][Full Text] [Related]
16. [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].
Nan YM; Fu N; Li WC; Kong LL; Yuan XW; Zhang SY; Liu LD; Lu Y; Cui LY
Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):687-694. PubMed ID: 29108191
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes.
Ahmed A; Wong RJ; Harrison SA
Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2062-70. PubMed ID: 26226097
[TBL] [Abstract][Full Text] [Related]
18. Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review.
Cui H; Zhang X
J Pediatr Endocrinol Metab; 2020 May; 33(5):579-584. PubMed ID: 32187014
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
Roeb E; Geier A
Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis.
Ratziu V; Ghabril M; Romero-Gomez M; Svegliati-Baroni G
Transplantation; 2019 Jan; 103(1):28-38. PubMed ID: 30300289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
